I agree, it makes sense to the accumulators, bless 'em.
The facts are that - apart from the Qty that's about to drop, the next few weeks shall also see the sp tagging some noticeable inflection points:
- Completion of Final pre-clinical Toxicology of PAT-DX1
- Completion of Master Cell Bank preparation of PAT-DX3.
- Completion of GMP Manufacturing process optimisation of PAT-DX3
IMO, completion of the above - which's already well underway - is the only thing holding BP from signing a deal.
Not Financial Advice DYOR
Ann: Patrys Receives R&D Tax Incentive Refund, page-12
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.37M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 28 | 5414724 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 2206958 | 6 |
View Market Depth
| Last trade - 12.32pm 17/07/2024 (20 minute delay) ? |
| PAB (ASX) Chart |
Day chart unavailable